Stock futures rise even as investors weigh Trump’s auto tariffs: Live updates

Stock futures rise even as investors weigh Trump’s auto tariffs: Live updates


Donald Trump is greeted by traders as he walks the floor of the New York Stock Exchange on Dec. 12, 2024.

Alex Brandon | AP

Stock futures were edged up early Thursday as investors weighed news of President Donald Trump’s 25% tariff aimed at foreign cars.

Futures tied to the Dow Jones Industrial Average rose 75 points, or 0.18%. S&P 500 futures increased 0.15%, while Nasdaq 100 futures were flat.

Trump had previously hinted that he would move to implement auto tariffs ahead of the April 2 date for reciprocal tariffs, which the president has labeled “Liberation Day.” The president since beginning his second term in January has discussed imposing duties on countries that have their own tariffs on U.S. imports. Trump also noted on Wednesday that his retaliatory tariffs will be permanent for his entire second term.

Shares of General Motors pulled back 7% in extended trading following Trump’s remarks, while Ford stock was 5% lower. Tesla stock gained about 1%.

The president said both where the car parts come from and where the finished production occurs will “have very strong policing.”

“It’s pretty easy to do, if parts are made in America and a car isn’t, those parts are not going to be taxed or tariffed,” Trump added.

Stocks took a leg lower and reached their lows of the session on Wednesday following news from the White House that Trump would announce the duties on imported cars later in the day.

The news comes as investors are already anxious about how Trump’s retaliatory tariffs will affect the broader U.S. economy, which is already showing some signs of weakness. Consumer confidence, for example, reached a 12-year low in March, according to a Conference Board report, in the latest indication of broader pessimism toward the economy. The board’s measure follows a similarly weak reading of the University of Michigan Survey of Consumers for March.

“Today was a reminder that despite the recent rebound in stocks, volatility remains as policy uncertainty lingers,” said Daniel Skelly, Head of Morgan Stanley’s Wealth Management market research and strategy team. “Moreover, next week’s tariff deadline will likely be more of a starting point for negotiations than a conclusion, so the market may struggle to recover in a straight line higher.”

Stocks are clinging to marginal gains this week. The S&P 500 has ticked up roughly 1% alongside the Nasdaq Composite. The 30-stock Dow has gained 1.1% so far this week.

On the economic front, investors will monitor fresh jobless claims data on Thursday, followed Friday by the March reading of the personal consumption expenditures price index. The PCE is the Federal Reserve’s preferred gauge of inflation.



Source

French PM suspends Macron’s flagship pension reform in search of support for budget
World

French PM suspends Macron’s flagship pension reform in search of support for budget

France’s Prime Minister Sebastien Lecornu addresses general political remarks to members of Parliament, at the French National Assembly, France’s lower house of parliament, in Paris, on October 14, 2025. Thomas Samson | Afp | Getty Images French Prime Minister Sebastien Lecornu on Tuesday suspended a landmark 2023 pension reform until after the 2027 presidential election, […]

Read More
Bessent tells the FT that struggling China wants ‘to pull everybody else down with them’
World

Bessent tells the FT that struggling China wants ‘to pull everybody else down with them’

U.S. Treasury Secretary Scott Bessent speaks to the press, on the day of U.S.-China talks on trade, economic and national security issues, in Madrid, Spain, September 15, 2025. Violeta Santos Moura | Reuters Treasury Secretary Scott Bessent accused China of trying to weaken the global economy by slapping export controls on resources vital for technology. […]

Read More
J&J to spin off orthopedics business, raises full-year forecast
World

J&J to spin off orthopedics business, raises full-year forecast

Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years. The health-care conglomerate also raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations. The company […]

Read More